Reports from research supported by EULAR

Please note: Research supported by EULAR is now regulated by FOREUM www.foreum.org

Vitamin D status in rheumatoid arthritis

European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO)
Leaders: Jelena Vojinovic, Angela Tincani
Manuscripts: Autoimmunity Reviews and Joint Bone Spine
 

Archive:

Orphan Disease Programme (ODP) on systemic sclerosis

This area of research resulted from the EULAR Orphan Disease Programme (ODP), which was begun in 2007: EULAR defined its strategic objectives for the period 2008-2012. As part of this strategy, the Executive Committee decided to launch a 4-year orphan disease programme focusing on systemic sclerosis to strengthen its activities in areas that are currently less prioritised.

The ODP programme started in January 2009, when the first call for project proposals was issued. The programme was open to the entire global scientific community; however, only applications where the Principal Investigator is based in Europe were considered.

The EULAR ODP on systemic sclerosis had two focus areas: Patho-physiology and/or therapy, and multi-centre projects. The programme is designed to fund a number of research projects (total budget of approx. 700,000 euros per year). Projects selected for funding need to pass a systematic evaluation process under the control of an independent Grant Advisory Council (GAC). All project proposals are peer reviewed.

ODP Projects:

Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis

Leader: Dr. Ariane Herrick

Regulatory networks underlying the pathogenesis of systemic sclerosis: Molecular correlates and determinants of outcome
Leader: Prof. Christopher Denton

Identification and validation of novel biomarkers in systemic sclerosis
Leaders: Dr. Oliver Distler
Prof. Francesco del Galdo

Identification of molecular targets in systemic sclerosis: exploiting functional genomics
Leader: Dr. Timothy Radstake

Effects of immunoablative therapy and autologous stem cell transplantation on pathogenetic pathways implicated in systemic sclerosis
Leader: Prof. Jacob van Laar

Related information

This page, Reports from research supported by EULAR, refers to projects carried out by EULAR together with other, third parties.